Ireland· IE-PA-PA2059/009/002
Levobupivacaine 1.25 mg/mL solution for infusion
A levobupivacaine product containing levobupivacaine, registered in Ireland by Fresenius Kabi Deutschland GmbH. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Levobupivacaine is registered in 10 of 19 countries.
Countries holding a registration under ATC N01BB10 (levobupivacaine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Levobupivacaine · ATC N01BB10
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- Sweden
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Levobupivacaine
- Manufacturer
- Fresenius Kabi Deutschland GmbH
- Country
- Ireland (IE)
- ATC code
- N01BB10
- ATC class
- Levobupivacaine
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2059/009/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
101 interactions on record for levobupivacaine.
Graded by severity as the source publishes them — 73 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levobupivacaine · interactions on record
101 records
- 73 moderate
- 28 minor
Most severe, free to view
- ClotrimazoleA01AB18moderate
- LidocainA01AE01moderate
- CimetidineA02BA01moderate
- AprepitantA04AD12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levobupivacaine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumChirocaine 1.25 mg/mlAbbvie
- SpainCHIROCANE 1,25 mg/ml SOLUCION PARA PERFUSIONAbbvie Spain, S.L.U.
- FranceLEVOBUPIVACAINE ALTAN 1,25 mg/mL, solution pour perfusionALTAN PHARMACEUTICALS (ESPAGNE)
- FinlandChirocaineAbbVie Oy
- NetherlandsLevobupivacaïne Fresenius Kabi 1,25 mg/ml, oplossing voor infusieFresenius Kabi Nederland B.V.
- United KingdomChirocaine 125mg/100ml infusion bagsAbbVie Ltd
- CzechiaLEVOBUPIVACAINE KABIFresenius Kabi s.r.o., Praha
- PolandLevobupivacaine MolteniL.Molteni & C. dei F.lli Alitti Societa di Esercizio S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Levobupivacaine Fresenius Kabi
- Czechia · Levobupivacaine Kabi
- Spain · Levobupivacaína Altan, Levobupivacaína Kabi
- France · Levobupivacaine Altan, Levobupivacaine Kabi
- United Kingdom (Northern Ireland) · Levobupivacaine, Levobupivacaine Altan
- Croatia · Levobupivakain Kabi
- Italy · Levobupivacaina Altan, Levobupivacaina Bioindustria L.I.M
- Netherlands · Levobupivacaïne Fresenius Kabi, Levobupivacaïne Molteni
- Poland · Levobupivacaine Molteni
- Portugal · Levobupivacaína Altan, Levobupivacaína Kabi
- Sweden · Levobupivacaine Molteni
- Slovenia · Levobupivakain Kabi
- Slovakia · Levobupivacaine Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/21ed45b9-939f-41ec-bdd9-62b3402254f9 GET /v1/drugs/21ed45b9-939f-41ec-bdd9-62b3402254f9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"routes": [
"Epidural use"
],
"source": "hpra",
"atc_all": [
"N01BB",
"N01BB10"
],
"strength": null,
"pa_number": "PA2059/009/002",
"substances": [
"Levobupivacaine"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "24/10/2014",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about levobupivacaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.